Why .25 Semaglutide Is Rarely the Target Maintenance Dose The 0.25 mg dose is designed as a starting point to monitor for gastrointestinal side effects (nausea, vomiting) and assess initial tolerability, not to deliver maximum therapeutic effect
Above 60% humidity, degradation accelerates substantially even at moderate temperatures
The goal is the minimum effective dose for maximum results with zero misery
Emergency medical attention is required if your blood pressure is very high (180/120 mmHg or higher) or if you have severe symptoms such as chest pain, severe headache with visual disturbance, difficulty breathing, or loss of consciousness
Retatrutide vs Amycretin: Why This Comparison Isn't Fair Yet Retatrutide beats amycretin/zenagamtide on every number but one is Phase 3, the other Phase 2
As compared to loop diuretics, SGLT2-i may distinctly regulate the interstitial versus intravascular compartment selectively reducing interstitial oedema, which has been observed in HF and DKD, with minimal change in blood volume
